Hydrocephalus Market Key Developments Trends, Analysis and Forecasts Till 2022

Global Hydrocephalus Market: Scenario Hydrocephalus is a medical condition, characterized by a build-up of cerebrospinal fluid within the brain, causing an expansion of brain-ventricles. Thus, the brain size increases in this disease and post ill effects include developmental and physical disabilities, the decline in memory, and others. The increasing prevalence of hydrocephalus and the rising demand for minimally invasive surgery are the major drivers for the market growth. According to a study published in the Gerontology and Geriatric Medicine Journal in 2016, the prevalence rate of normal pressure hydrocephalus varies from 0.3% to 3.0% in patients who age 65 years or more. Additionally, the rising per capita healthcare expenditure and rising pediatric population boost the market growth. According to the Hydrocephalus Association in 2015, approximately one in every 1,000 infants is estimated to be born with the disease. However, factors such as lack of awareness and the high cost of therapeutic surgery followed by the related risks of meningitis, seizure, and others are estimated to restrain the market during the forecast period. Hydrocephalus Market: Segmentation The global hydrocephalus market is segmented on the basis of type, diagnosis, treatment, and end user. On the basis of type, the market is segmented into congenital hydrocephalus, compensated hydrocephalus, normal pressure hydrocephalus, and others. On the basis of diagnosis, the market is categorized into neurological exam, lumber test, brain imaging, and others. The lumber test segment is sub-segmented into lumbar puncture, lumbar drainage test, and others. The brain imaging segment is sub-segmented into ultrasound, Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), and others. On the basis of treatment, the market is segmented into surgery, diuretics, and others. The surgery segment is sub-segmented into shunt surgery, Endoscopic Third Ventriculostomy (ETV), and others. The diuretics segment is sub-segmented into acetazolamide, furosemide, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, and others. Hydrocephalus Market: Regional Analysis The Americas dominates the global hydrocephalus market owing to the rising prevalence of hydrocephalus, the presence of a well-developed healthcare sector, and major market players within the region. Additionally, the growing pediatric population and rising healthcare expenditure boost the market growth. On a regional basis, the Americas is divided into North America and South America. North America is estimated to lead the market due to the presence of developed economies such as the US and Canada within the region. On the other hand, South America is estimated to be the fastest growing region for the market. Europe stands second in the global hydrocephalus market. This can be due to the increasing availability of funds for research, a huge patient population, and a well-developed healthcare sector. Additionally, the increasing pediatric population provides favorable backgrounds for the market growth within the region. The child population, aging in between 0 to 14 years is estimated to increase from 17.6% of the total population in 2013 to 18.4% of the total population by 2020. Regionally, Europe is divided into Western Europe and Eastern Europe. Eastern Europe is the fastest growing region, and Western Europe is estimated to lead the market. Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/1719

Turn static files into dynamic content formats.

Create a flipbook